COVID-19

This week’s research roundup features: Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: An ECOG-ACRIN cancer research group trial (E3311).

Topic's Include: Mayo Clinic expert discusses how COVID-19 vaccination during pregnancy may protect babies after birth, and Mayo Clinic in Rochester to ease visitor restrictions for hospital patients.

Today's Highlights Include: Mayo experts encourage booster doses, caution against dropping masks, Black history month: Health & Wellness, and 13 processed foods that are actually healthy.

This week on "Answers From the Lab,” William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, hosts this week’s "Answers From the Lab" podcast. Dr. Morice is joined by David McClintock, M.D., a Mayo Clinic pathologist who specializes in computational pathology and AI, to discuss how informatics is enhancing and changing the practice of laboratory medicine.

This week’s research roundup features: Deep residual inception encoder-decoder network for amyloid PET harmonization.

Topic's Include: Cases down, but Mayo Clinic expert says COVID-19 pandemic isn’t over, and community leaders and Mayo Clinic researchers develop playbook for COVID-19 health equity, future pandemics.

Today's Highlights Include: Reports Russian skater took banned drug trimetazidine puzzle experts, many Minneapolis employers rebooting return-to-office plans, and CDC expected to update mask guidance as early as next week.

This week on "Answers From the Lab,” William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. In this episode, Dr. Morice and Dr. Pritt consider how COVID-19 precautions may shift as the omicron surge ebbs, and how labs will adapt as the pandemic continues to change.

This week’s research roundup features: Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.

Topic's Include: Mayo Clinic in Rochester eases visitor restrictions for pediatric hospital patients, and ask the Mayo Mom: More than 2 years of COVID-19 takes its toll on children, families.

Today's Highlights Include: Biden officials trying to recalculate U.S. Covid-19 hospitalizations, CVS, Walgreens remove limits on at-home COVID-19 tests, and is it time to phase out masks in schools? Why more states and doctors are saying yes.

This week on "Answers From the Lab,” William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. In this episode, Dr. Morice and Dr. Pritt discuss the importance of properly interpreting lab test results, and they review the crucial difference between screening tests and diagnostic tests.

Experts at Mayo Clinic have developed a unique method of testing that combines new technology with novel bioinformatics to promptly detect a group of uncommon genetic conditions that are often difficult to identify.